- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Chemotherapy and Cardiac Arrhythmias: A Review
Authors
Keywords
Atrial Fibrillation, Sorafenib, Ventricular Tachycardia, Sunitinib, Bortezomib
Journal
DRUG SAFETY
Volume 38, Issue 2, Pages 129-152
Publisher
Springer Nature
Online
2015-01-10
DOI
10.1007/s40264-014-0258-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Acute I Kr Block Is Insufficient to Detect Torsades de Pointes Liability
- (2014) Tao Yang et al. CIRCULATION
- Incidence and Risk of Cardiotoxicity Associated with Bortezomib in the Treatment of Cancer: A Systematic Review and Meta-Analysis
- (2014) Yi Xiao et al. PLoS One
- Cancer Therapy–Induced Cardiotoxicity: Basic Mechanisms and Potential Cardioprotective Therapies
- (2014) Virginia Shalkey Hahn et al. Journal of the American Heart Association
- Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: A systematic review of incidence, manifestations and predisposing factors
- (2013) Anne Polk et al. CANCER TREATMENT REVIEWS
- Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
- (2013) Steven E. Lipshultz et al. CIRCULATION
- Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- Cancer Genetics and the Cardiotoxicity of the Therapeutics
- (2013) Hind Lal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Overview and Management of Cardiac Adverse Events Associated With Tyrosine Kinase Inhibitors
- (2013) D. J. Lenihan et al. ONCOLOGIST
- QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: A case report and review of the literature
- (2012) Donald R. Lynch Jr et al. Cardiology Journal
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- Drug-induced atrial fibrillation
- (2012) Juan Tamargo et al. Expert Opinion On Drug Safety
- Clinical cardiac safety profile of nilotinib
- (2012) T. D. Kim et al. HAEMATOLOGICA
- A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors
- (2012) Thierry Lesimple et al. INVESTIGATIONAL NEW DRUGS
- Incidence and Risk of QTc Interval Prolongation among Cancer Patients Treated with Vandetanib: A Systematic Review and Meta-analysis
- (2012) Jiajie Zang et al. PLoS One
- Phase II trial of sorafenib in combination with 5-fluorouracil infusion in advanced hepatocellular carcinoma
- (2011) Iacopo Petrini et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Novel Preclinical Strategy for Identifying Cardiotoxic Kinase Inhibitors and Mechanisms of Cardiotoxicity
- (2011) Hui Cheng et al. CIRCULATION RESEARCH
- Melphalan-Induced Supraventricular Tachycardia: Incidence and Risk Factors
- (2011) Victor Feliz et al. CLINICAL CARDIOLOGY
- Pharmacogenomic Prediction of Anthracycline-Induced Cardiotoxicity in Children
- (2011) Henk Visscher et al. JOURNAL OF CLINICAL ONCOLOGY
- Asymptomatic Profound Sinus Bradycardia (Heart Rate ≤45) in Non-small Cell Lung Cancer Patients Treated with Crizotinib
- (2011) Sai-Hong Ignatius Ou et al. Journal of Thoracic Oncology
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations
- (2011) J.D. Cohen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results
- (2010) H. M. Kantarjian et al. BLOOD
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- Cardiovascular effects of systemic cancer treatment
- (2010) Elżbieta Senkus et al. CANCER TREATMENT REVIEWS
- Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology
- (2010) Thomas Eschenhagen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype
- (2010) Mari Pekkanen-Mattila et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Cardiotoxicity with 5-fluorouracil and capecitabine: more than just vasospastic angina
- (2010) T. Stewart et al. INTERNAL MEDICINE JOURNAL
- Paclitaxel accelerates spontaneous calcium oscillations in cardiomyocytes by interacting with NCS-1 and the InsP3R
- (2010) Kun Zhang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Drug-Induced Long QT Syndrome
- (2010) P. Kannankeril et al. PHARMACOLOGICAL REVIEWS
- Cardiac Toxicity From Systemic Cancer Therapy: A Comprehensive Review
- (2010) Giuseppe Curigliano et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Cardiotoxicity Associated with Targeting Kinase Pathways in Cancer
- (2010) Howard R. Mellor et al. TOXICOLOGICAL SCIENCES
- The cardiotoxicity and myocyte damage caused by small molecule anticancer tyrosine kinase inhibitors is correlated with lack of target specificity
- (2010) Brian B. Hasinoff TOXICOLOGY AND APPLIED PHARMACOLOGY
- Electrocardiographic Characterization of the QTc Interval in Patients with Advanced Solid Tumors: Pharmacokinetic- Pharmacodynamic Evaluation of Sunitinib
- (2009) C. L. Bello et al. CLINICAL CANCER RESEARCH
- Evaluation and Management of Cardiac Safety Using the Electrocardiogram in Oncology Clinical Trials: Focus on Cardiac Repolarization (QTc Interval)
- (2009) J Morganroth et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Introducing a new entity: chemotherapy-induced arrhythmia
- (2009) M. Guglin et al. EUROPACE
- Fluoropyrimidine-associated cardiotoxicity: revisited
- (2009) M Wasif Saif et al. Expert Opinion On Drug Safety
- Cardiovascular Complications of Cancer Therapy
- (2009) Edward T.H. Yeh et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
- Cardiovascular toxicity caused by cancer treatment: strategies for early detection
- (2009) Renske Altena et al. LANCET ONCOLOGY
- Thalidomide for treatment of multiple myeloma: 10 years later
- (2008) A. Palumbo et al. BLOOD
- Both EGFR kinase and Src-related tyrosine kinases regulate human ether-à-go-go-related gene potassium channels
- (2008) De-Yong Zhang et al. CELLULAR SIGNALLING
- Sprycel for Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Resistant to or Intolerant of Imatinib Mesylate
- (2008) M. Brave et al. CLINICAL CANCER RESEARCH
- The Diagnosis and Management of Cardiovascular Disease in Cancer Patients
- (2008) Syed Wamique Yusuf et al. CURRENT PROBLEMS IN CARDIOLOGY
- Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles
- (2008) Sharon L. Sanborn et al. INVESTIGATIONAL NEW DRUGS
- Anthracycline Cardiotoxicity: From Bench to Bedside
- (2008) Luca Gianni et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
- (2008) Manuela Schmidinger et al. JOURNAL OF CLINICAL ONCOLOGY
- An evaluation of the cardiotoxicity of imatinib mesylate
- (2008) Antonio Luiz Ribeiro et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation